German pricing rules hit Eisai’s HalavenDrug has “no additional benefit” in metastatic liposarcoma, says IQWiG. Share XGerman pricing rules hit Eisai’s Halavenhttps://pharmaphorum.com/news/german-pricing-rules-hit-eisais-halaven/